CD226 and central nervous system cancer: Tyrosine-based inhibitory motif and DNAX accessory molecule 1 potentially interact with CD112 known as poliovirus receptor–related protein 2 (10), which was found to be expressed in glioma stem cells at a lower level compared with poliovirus receptor (Figure 1, D).